Schizophrenia Research
Volume 112, Issue 1 , Pages 32-45 , July 2009

Workshop on defining the significance of progressive brain change in schizophrenia: December 12, 2008 American College of Neuropsychopharmacology (ACNP) all-day satellite, Scottsdale, Arizona: The rapporteurs' report

  • Stefan J. Borgwardt

      Affiliations

    • University Hospital Basel, Psychiatric Outpatient Department, Petersgraben 4, CH-4031 Basel, Switzerland
    • King's College London, Institute of Psychiatry, De Crespigny Park, London SE5 8AF, UK
    • ,
  • Chandlee Dickey

      Affiliations

    • The Brockton Boston VA Healthcare System, Psychiatry, 116A, 940 Belmont Avenue, Brockton, Massachusetts, 02301, United States
    • Harvard Medical School, Boston, Massachusetts USA
    • ,
  • Hilleke Hulshoff Pol

      Affiliations

    • The University of Utrecht, Utrecht, The Netherlands
    • ,
  • Thomas J. Whitford

      Affiliations

    • Psychiatry Neuroimaging Laboratory, Brigham and Women's Hospital, Harvard Medical School, United States
    • Tel.: +1 617 525 6119; fax: +1 617 525 6150.
    • ,
  • Lynn E. DeLisi

      Affiliations

    • The Brockton Boston VA Healthcare System, Psychiatry, 116A, 940 Belmont Avenue, Brockton, Massachusetts, 02301, United States
    • Harvard Medical School, Boston, Massachusetts USA
    • Corresponding Author InformationCorresponding author.

Received 23 February 2009 ,Revised 19 April 2009 ,Accepted 21 April 2009.

References 

  1. Allen PE, Amaro CH, Fu SC, Williams MJ, Brammer LC, Johns LC, et al. Neural correlates of the misattribution of speech in schizophrenia. Br. J. Psychiatry. 2007;190:162–169
  2. Borgwardt SJ, McGuire PK, Aston J, Berger G, Dazzan P, Gschwandtner U, et al. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br. J. Psychiatry. 2007;(Suppl 51):s69–75
  3. Borgwardt SJ, Riecher-Rossler A, Dazzan P, Chitnis X, Aston J, Drewe M, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol. Psychiatry. 2007;61(10):1148–1156
  4. Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pfluger MO, Stieglitz RD, et al. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr. Res. 2008;106(2–3):108–114
  5. Brans RGH, van Haren NEM, van Baal GCM, Schnack HG, Kahn RS, Hulshoff Pol HE. Heritability of changes in brain volume over time in twin pairs discordant for schizophrenia. Arch. Gen. Psychiatry. 2008;65(11):1259–1268
  6. Broome MR, Matthiasson P, Fusar-Poli P, Woolley JB, Johns LC, Tabraham P, et al. Neural correlates of executive function and working memory in the ‘at-risk mental state’. Br. J. Psychiatry. 2009;194:25–33
  7. Cahn W, Hulshoff Pol HE, Lems EB, van Haren NE, Schnack HG, van der Linden JA, et al. Brain volume changes in first-episode schizophrenia: a 1-year follow-up study. Arch. Gen. Psychiatry. 2002;59:1002–1010
  8. Cahn W, Rais M, Stigter FP, van Haren NE, Caspers E, Hulshoff Pol HE, et al. Psychosis and brain volume changes during the first five years of schizophrenia. Eur. Neuropsychopharmacol. 2009;19(2):147–151
  9. Crow TJ, Ball J, Bloom S, Brown R, Bruton CJ, Colter N, et al. Schizophrenia as an anomaly of development of cerebral asymmetry: a postmortem study and a proposal concerning the genetic basis of the disease. Arch. Gen. Psychiatry. 1989;46:1145–1150
  10. Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, et al. Ventricular enlargement in poor-outcome schizophrenia. Biol. Psychiatry. 1998;43(11):783–793
  11. Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitinis X, Suckling J, et al. Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the AESOP study. Neuropsychopharmacology. 2005;30:765–774
  12. Degreef G, Ashtari M, Wu HW, Borenstein M, Geisler S, Lieberman J. Follow-up MRI study in first episode schizophrenia. Schizophr. Res. 1991;5:204–206
  13. DeLisi LE. Defining the course of brain structural growth and plasticity in schizophrenia. Psychiatry Research Neuroimaging. 1999;92(1):1–9
  14. DeLisi LE. The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia?. Curr. Opin. Psychiatry. 2008;21(2):140–150
  15. DeLisi LE. The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia. Schizophr. Bull. 2008;34(2):312–321
  16. DeLisi LE, Lieberman JA. Introduction. Proceedings from the ACNP satellite meeting: longitudinal perspectives on the pathophysiology of schizophrenia. Schizophr. Res. 1991;5:183–210
  17. DeLisi LE, Hoff A, Schwartz J, Shields G, Halthore S, Gupta S, et al. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol. Psychiatry. 1991;29:159–175
  18. DeLisi LE, Stritzke PH, Holan V, et al. Brain morphological changes in 1st episode cases of schizophrenia: are they progressive? Proceedings from the ACNP satellite meeting: longitudinal perspectives on the pathophysiology of schizophrenia. Schizophr. Res. 1991;5(19):2060150–208
  19. DeLisi LE, Stritzke P, Riordan H, Holan V, Boccio A, Kushner M, et al. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biol. Psychiatry. 1992;31:241–254
  20. DeLisi LE, Tew W, Xie S, Hoff AL, Sakuma M, Kushner M, et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol. Psychiatry. 1995;38(6):349–360
  21. DeLisi LE, Grimson R, Sakuma M, Tew W, Kushner M, Hoff AL. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatr. Res. Neuroimaging. 1997;74:129–140
  22. DeLisi LE, Sakuma M, Kushner M. Association of brain structural change with the heterogeneous course of schizophrenia from early childhood through five years subsequent to a first hospitalization. Psychiatry Res. (Neuroimaging). 1998;84:75–88
  23. DeLisi LE, Sakuma M, Maurizio A, Hoff AL. Cerebral ventricular change over the first 10 years after the onset of schizophrenia. Psychiatry Res. (Neuroimaging). 2004;130:57–70
  24. Dickey CC, Salisbury DF, Nagy AI, Hirayasu Y, Lee CU, McCarley RW, et al. Follow-up MRI study of prefrontal volumes in first-episode psychotic patients. Schizophr. Res. 2004;71(2–3):349–351
  25. Dorph-Petersen KA, Pierri JN, Perel JM, Sun Z, Sampson AR, Lewis DA. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology. 2005;30:1649–1661
  26. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?. J. Psychiatr. Res. 1982–83;17:319–334
  27. Fitzsimmons J, Kubicki M, Smith K, Bushell G, Estepar RS, Westin CF, et al. Diffusion tractography of the fornix in schizophrenia. Schizophr. Res. 2009;107(1):39–46
  28. Fornito A, Yucel M, Wood SJ, Adamson C, Velakoulis D, Saling MM, et al. Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum. Brain Mapp. 2008;29(4):478–489
  29. Fu CH, Brammer MJ, Yaguez L, Allen P, Matsumoto K, Johns L, et al. Increased superior temporal activation associated with external misattributions of self-generated speech in schizophrenia. Schizophr. Res. 2008;100(1–3):361–363
  30. Gur RE, Cowell P, Turetsky BL, Gallacher F, Cannon T, Bilker W, et al. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomic changes to clinical and neurobehavioral measures. Arch. Gen. Psychiatry. 1998;55:145–152
  31. Haug JO. Pneumoencephalographic studies in mental disease. Acta Psychiatr. Scand. 1963;(Suppl 38):11–104
  32. Haug JO. Pneumoencephalographic evidence of brain atrophy in acute and chronic schizophrenic patients. Acta Psychiatr. Scand. 1982;66:374–383
  33. Ho B-C, Andreasen NC, Nopoulos P, Arndt S, Magnotta V, Flaum M. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch. Gen. Psychiatry. 2003;60:585–594
  34. Howes OD, Montgomery AJ, Asselin MC, Murray RM, Valli I, Tabraham P, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch. Gen. Psychiatry. 2009;66(1):13–20
  35. Huber G. Pneumoencephalographische und psychopathologische bilder bei endogen psychosen. Berlin, Germany: Springer; 1957;
  36. Hulshoff Pol HE, Kahn RS. What happens after the first episode? A review of progressive brain changes in chronically ill patients with schizophrenia. Schizophr. Bull. 2008;34(2):354–366
  37. Huttenlocher PR. Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Res. 1979;163:195–205
  38. Illowsky BP, Juliano DM, Bigelow LBG, Weinberger DR. Stability of C.T. scan findings in schizophrenia: results of an 8 year follow-up study. J. Neurol. Neurosurg. Psychiatry. 1998;51:209–213
  39. Jacobi W, Winkler H. Encephalographische studien an chronische schizophrenen. Arch. Psychiatr. Nervenkr. 1927;81:299–332
  40. Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S, et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am. J. Psychiatry. 1998;155:678–685
  41. James AC, Javaloyes A, James S, Smith DM. Evidence for non-progressive changes in adolescent-onset schizophrenia: follow-up magnetic resonance imaging study. Br. J. Psychiatry. 2002;180:339–344
  42. Jaskiw GE, Juliano DM, Goldberg TE, Hertzman M, Urow-Hamell E, Weinberger DR. Cerebral ventricular enlargement in schizophreniform disorder does not progress: a seven year follow-up study. Schizophr. Res. 1994;14:23–28
  43. Job DE, Whalley HC, Johnstone EC, Lawrie SM. Grey matter changes over time in high risk subjects developing schizophrenia. Neuroimage. 2005;25:1023–1030
  44. Job DE, Whalley HC, McIntosh AM, Owens DGC, Johnstone EC, Lawrie SM. Grey matter changes can improve the prediction of schizophrenia in subjects at high risk. BMC Med. 2006;4:29
  45. Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet. 1976;2:924–926
  46. Kasai K, Shenton ME, Salisbury DF, Hirayasu Y, Onitsuka T, Spencer MH, et al. Progressive decrease in left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry. 2003;60(8):766–775
  47. Kasai K, Shenton M, Salisbury DF, Hirayasu Y, Lee CU, Ciszewski AA, et al. Progressive decrease of left temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am. J. Psychiatry. 2003;160:156–164
  48. Keller A, Castellanos FX, Vaituzis AC, Jeffries NO, Giedd JN, Rapoport JL. Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am. J. Psychiatry. 2003;160:128–133
  49. Kemali D, Maj M, Galderisi S, Milici N, Salvati A. Ventricle–brain ratio in schizophrenia: a controlled follow-up study. Biol. Psychiatry. 1989;26:756–759
  50. Konopaske G, Dorph-Petersen K, Sweet R, Pierri J, Zhang W, Sampson A, et al. Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol. Psychiatry. 2008;63:759–765
  51. Koo MS, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch. Gen. Psychiatry. 2008;65(7):746–760
  52. Kraepelin E. Lehrbuch der Psychiatrie. 5 and 6 Aufl.. Lepzig: Barth; 1896 and 1899;
  53. Kraepelin E. Dementia Praecox and Paraphrenia. In:  Barclay RM editors. 1971 ed.. New York, NY: Krieger; 1919;Translated by
  54. Kumari V, Fannon D, Ffytche DH, Raveendran V, Antonova E, Premkumar P, et al. Functional MRI of verbal self-monitoring in schizophrenia: performance and illness-specific effects. Schizophr. Bull. 2008;Nov 7, PMID: 18997158 Electronic publication
  55. Lappin JM, Dazzan P, Morgan K, Morgan C, Chitnis X, Suckling J, et al. Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis. Br. J. Psychiatry. 2007;(Suppl 51):s123–7
  56. Lawrie SM, Whalley HC, Abukmeil SS, Kestelman JN, Miller P, Best JJ, et al. Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms. Br. J. Psychiatry. 2002;181:138–143
  57. Lee K, Yoshida T, Kubicki M, Bouix S, Westin CF, Kindlmann G, et al. Increased diffusivity in superior temporal gyrus in patients with schizophrenia: a diffusion tensor imaging study. Schizophr. Res. 2009;Jan 8, PMID: 19135872., Electronic publication
  58. Lidz T, Fleck S, Cornelison A, Terry D. The intrafamilial environment of the schizophrenic patient. IV. Parental personalities and family interaction. Am. J. Orthopsychiatr. 1958;28:764–776
  59. Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, et al. The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches. Biol. Psychiatry. 2001;50(11):884–897(Erratum in: Biol Psychiatry 2002 Feb 15;51(4):346.)
  60. Lieberman J, Chakos M, Wu H, et al. Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psychiatry. 2001;49:487–499
  61. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, Kahn RS, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch. Gen. Psychiatry. 2005;62(4):361–370
  62. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch. Gen. Psychiatry. 2001;58:148–157
  63. Mitelman SA, Brickman AM, Shihabuddin L, Newmark RE, Hazlett EA, Haznedar MM, et al. A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia. Neuroimage. 2007;37(2):449–462
  64. Moore MD, Nathan AR, Elliot G. Encephalographic studies in mental disease. Am. J. Psychiatry. 1935;92:43–67
  65. Morgan KD, Dazzan P, Orr KG, Hutchinson G, Chitnis X, Suckling J, et al. Grey matter abnormalities in first-episode schizophrenia and affective psychosis. Br. J. Psychiatry. 2007;(Suppl 51):s111–6
  66. Murray RM, Jones P, O'Callaghan E. Fetal brain development and later schizophrenia. Ciba Found. Symp. 1991;156:155–163
  67. Nakamura M, Salisbury DF, Hirayasu Y, Bouix S, Pohl KM, Yoshida T, et al. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol. Psychiatry. 2007;62(7):773–783
  68. Nasrallah HA, Olson SC, Mccalley-Whittiers M, Chapman S, Jacoby CG. Cerebral ventricular enlargement in schizophrenia: a preliminary follow-up study. Arch. Gen. Psychiatry. 1986;43:157–159
  69. Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361(9354):281–288
  70. Prata DP, Mechelli A, Fu CH, Picchioni M, Kane F, Kalidindi S, et al. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia. Biol. Psychiatry. 2008;Dec 1. PMID: 19054502, Electronic publication
  71. Puri BK, Hutton SB, Saeed N, Oatridge A, Hajnal JV, Duncan L, et al. A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Res. 2001;106:141–150
  72. Rais M, Cahn W, Van Haren N, Schnack H, Caspers E, Hulshoff Pol H, et al. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am. J. Psychiatry. 2008;165(4):490–496
  73. Rapoport JL, Giedd J, Kumra S, Jacobsen L, Smith A, Lee P, et al. Childhood-onset schizophrenia: progressive ventricular change during adolescence. Arch. Gen. Psychiatry. 1997;54:897–903
  74. Saijo T, Abe T, Smeya Y, Sassa T, Sudo Y, Suhara T, et al. Ten year progressive ventricular enlargement in schizophrenia: an MRI morphometrical study. Psychiatry Clin. Neurosci. 2001;55:41–47
  75. Schaufelberger MS, Duran FL, Lappin JM, Scazufca M, Amaro E, Leite CC, et al. Grey matter abnormalities in Brazilians with first-episode psychosis. Br. J. Psychiatry. 2007;(Suppl. 51):s117–22
  76. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr. Res. 2001;49:1–52
  77. Sponheim SR, Iacono WG, Beiser M. Stability of ventricular size after the onset of psychosis in schizophrenia. Psychiatr. Res: Neuroimaging. 1991;40:21–29
  78. Sporn AL, Greenstein DK, Gogtay N, Jeffries NO, Lenane M, Gochman P, et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am. J. Psychiatry. 2003;160(12):2181–2189
  79. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br. J. Psychiatry. 2006;188:510–518
  80. Sun D, Stuart GW, Jenkinson M, Wood SJ, McGorry PD, Velakoulis D, et al. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol. Psychiatry. 2008;July 8. PMID: 18607377. Electronic publication
  81. Takahashi T, Suzuki M, Tanino R, Zhou SY, Hagino H, Niu L, et al. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatry Res. 2007;154(3):209–219
  82. Takahashi T, Suzuki M, Tanino R, Zhou S-Y, Hagino H, Niu L, et al. Volume reduction of the left planum temporale gray matter associated with long duration of untreated psychosis in schizophrenia: a preliminary report. Psychiatr. Res: Neuroimaging. 2007;154:209–219
  83. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001;98:11650–11655
  84. van Haren NE, Hulshoff Pol HE, Schnack HG, Cahn W, Brans R, Carati I, et al. Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol. Psychiatry. 2008;63(1):106–113
  85. Vidal CN, Rapoport JL, Hayashi KM, Geaga JA, Sui Y, McLemore LE, et al. Dynamically spreading frontal and cingulated deficits mapped in adolescents with schizophrenia. Arch. Gen. Psychiatry. 2006;63:25–34
  86. Vita A, Sacchetti E, Valvassori G, Cazullo CL. Brain morphology in schizophrenia: a 2–5 year CT scan follow-up study. Acta Psychiatr. Scand. 1988;78:618–621
  87. Vita A, Giobbio GM, Dieci M, Garbarini M, Morganti C, Comazzi M, et al. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia. Biol. Psychiatry. 1994;35:960–962
  88. Vita A, Sacchetti E, Valvassori G, Cazullo CL. Brain morphology in schizophrenia: a 2–5 year CT scan follow-up study. Acta Psychiatr. Scand. 1998;78:618–621
  89. Vita A, De Peri L, Silenzi C, Dieci M. Brain morphology in first-episode schizophrenia: a meta-analysis of quantitative magnetic resonance imaging studies. Schizophr. Res. 2006;82:75–88
  90. Weinberger DR, Torrey EF, Neophytides AN, Wyatt RJ. Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch. Gen. Psychiatry. 1979;36(7):735–739
  91. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry. 1987;44:660–669
  92. Weinberger DR, DeLisi LE, Perman GP, Targum S, Wyatt RJ. Computed tomography in schizophreniform disorder and other acute psychiatric disorders. Arch. Gen. Psychiatry. 1982;39(7):778–783
  93. Whalley HC, Gountouna VE, Hall J, McIntosh AM, Simonotto E, Job DE, et al. fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia. Psychol. Med. 2008;1–11. PMID: 19105855, Electronic publication
  94. Whitford TJ, Grieve SM, Farrow TFD, Gomes L, Brennan J, Harris AWF, et al. Progressive grey matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage. 2006;32:511–519
  95. Whitford TJ, Thomas JG, Farrow SM, Gomes L, Brennan J, Harris AW, et al. Progressive gray matter atrophy over the first 2–3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage. 2006;32:511–519
  96. Whitford TJ, Grieve SM, Farrow TFD, Gomes L, Brennan J, Harris AWF, et al. Volumetric white matter abnormalities in first-episode schizophrenia: a longitudinal, tensor-based morphometry study. Am. J. Psychiatry. 2007;164:1082–1089
  97. Woods BT, Yurgelun-Todd D, Benes FM, Frankenburg FR, Pope HC, McSparren J. Progressive ventricular enlargement in schizophrenia: comparison to bipolar affective disorder and correlation to clinical course. Biol. Psychiatry. 1990;27:341–352
  98. Wood SJ, Velakoulis D, Smith DJ, Bond D, Stuart GW, McGorry PD, et al. A Longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia. Schizophr. Res. 2001;52:37–46
  99. Wood SJ, Pantelis C, Velakoulis D, Yücel M, Fornito A, McGorry PD. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr. Bull. 2008;34(2):322–329(Electronic publication ahead of print 2008 Jan 16)
  100. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am. J. Psychiatry. 2000;157(1):16–25
  101. Yoshihara Y, Suqihara G, Matsumoto H, Suckling J, Nishimura K, Toyoda T, et al. Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann. Gen. Psychiatry. 2008;7(1):25
  102. Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch. Gen. Psychiatry. 2008;65:694–701

☆ Rapporteurs are alphabetically listed. Each equally contributed to this report.

PII: S0920-9964(09)00212-6

doi: 10.1016/j.schres.2009.04.025

Schizophrenia Research
Volume 112, Issue 1 , Pages 32-45 , July 2009

Article Tools

* Image Usage & Resolution